Cited by 889Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Management and Education

The DOI matches its Crossref record.

Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993

Gu, Ken, Cowie, Catherine C, Harris, Maureen I·1998·Diabetes Care

DOI 10.2337/diacare.21.7.1138

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine 22-year mortality (1971-1993), causes of death, life expectancy, and survival in a national sample of diabetic and nondiabetic adults according to age, sex, and race. RESEARCH DESIGN AND METHODS: A representative national cohort of 14,374 adults aged 25-74 years was identified in 1971-1975 in the First National Health and Nutrition Examination Survey (NHANES I). Diabetes was ascertained by medical history interview. The cohort was followed for mortality through 1992-1993, with verification of vital status for 96.2% (n = 13,830). Causes of death were determined from death certificates. RESULTS: Diabetic subjects comprised 5.1% of the cohort and accounted for 10.6% of the deaths. Mortality for diabetic subjects increased from 12.4 per 1,000 person-years for those aged 25-44 years at baseline to 89.7 per 1,000 person-years for those aged 65-74 years. The age-adjusted mortality rate was 57% higher for diabetic men than for diabetic women; the rate was 27% higher for diabetic non-Hispanic blacks than for diabetic non-Hispanic whites. Mortality rates were highest for insulin-treated subjects and for those with > or = 15 years' duration of diabetes. Diabetes was listed on the death certificate as the underlying cause of death for only 7.7% of diabetic men and 13.4% of diabetic women. Considering multiple causes of death, heart disease was listed the most frequently and was present on 69.5% of death certificates of people with diabetes. Death rates were higher for diabetic than for nondiabetic subjects in all age, sex, and race groups. The relative risk of death (diabetic versus nondiabetic subjects) declined with age from a value of 3.6 for those aged 25-44 years at baseline to 1.5 for those aged 65-74 years. The relative risk was elevated in diabetic subjects for all major causes of death except malignant neoplasms. Survival of diabetic subjects was lower than that of nondiabetic subjects in all age, sex, and race groups. Median life expectancy was 8 years lower for diabetic adults aged 55-64 years and 4 years lower for those aged 65-74 years. CONCLUSIONS: In this representative national sample of adults, mortality rates were higher for diabetic men than for diabetic women and for diabetic blacks than for diabetic whites. The study confirms the substantially higher risk of death, lower survival, and lower life expectancy of diabetic adults compared with nondiabetic adults.

Integrity signals

Registry

Crossref · 10.2337/diacare.21.7.1138

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–600 of 889

Management of Diabetic Dyslipidemia
Khera, A., & McGuire, D. K. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505020-00002 · Cited by 12
Ethnic Differences in Quality of Life in Insured Older Adults with Diabetes Mellitus in an Integrated Delivery System
Laiteerapong, N., Karter, A. J., John, P. M., Schillinger, D., Moffet, H. H., Liu, J. Y., Adler, N., Chin, M. H., & Huang, E. S. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12327 · Cited by 13
“Another limitation is that this study may not have fully captured the medical conditions that explain HRQL, although it included 13 chronic conditions that have been associated with important decrements in HRQL in older adults with diabetes mellitus(15) and are highly prevalent diseases associated with mortality.(45)…”
Background
Impact of Anxiety Disorders on Mortality for Persons With Diabetes: A National Population-Based Cohort Study
Huang, C., Hsieh, H., Chiu, H., Wang, P., Lee, M., Li, C.-Y., & Lin, C. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.11.009 · Cited by 13
Mortalidad en una cohorte de pacientes con diabetes tipo 2 del Área de Alcañiz
Orna, J. A. G., Juliani, B. B., Arnal, L. M. L., & Castro-Alonso, F. J. (2002) · Anales de Medicina Interna · doi:10.4321/s0212-71992002000700003 · Cited by 13
Effect of parental hypertension and/or parental diabetes on hypertension in Taiwanese diabetic patients
Tseng, C. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01875.x · Cited by 13
Progress in the Estimation of Mortality due to Diabetes
Boyko, E. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2320 · Cited by 13
Cardiovascular risk factors in Saudi Arabian and non-Saudi Arabian diabetic patients in Saudi Arabia.
Akbar, D., Ahmed, M. M., & Algamdi, A. (2003) · Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit · doi:10.26719/2003.9.5-6.884 · Cited by 13
New onset diabetes in adulthood is associated with a substantial risk for mortality at all ages: a population based historical cohort study with a decade-long follow-up
Zucker, I., Shohat, T., Dankner, R. S., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0583-x · Cited by 12
“In most studies the highest relative risk was observed in the youngest age groups [4, 5], but in a study from Canada and the UK, the highest relative risk for mortality was observed in the 45–64 year age group [6].”
Background
Silent myocardial ischaemia and risk factors in a diabetic Afro-Caribbean population
Blanchet‐Deverly, A., AMARA, M. D. S. S. M. F., Larifla, L., Vélayoudom‐Céphise, F., Roques, F., Kangambega, P., Hue, K., & Foucan, L. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.05.006 · Cited by 12
Cardioprotective effect of β- d -mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model
Mortazavi‐Jahromi, S. S., Alizadeh, S., Javanbakht, M. H., & Mirshafiey, A. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1455209 · Cited by 12
“5 time higher risk of death from heart disease than healthy control [5].”
Background
Mortality in diabetes mellitus: revisiting the data from a developing region of the world
Mohan, V., & Pradeepa, R. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.075606 · Cited by 12
Burden attributable to Cardiometabolic Diseases in Zimbabwe: a retrospective cross-sectional study of national mortality data
Mutowo, M. P., Owen, A. J., Billah, B., Lorgelly, P. K., Gumbie, K. E., Mangwiro, J. C., & Renzaho, A. M. N. (2015) · BMC Public Health · doi:10.1186/s12889-015-2554-z · Cited by 11
Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up
Tseng, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147916 · Cited by 12
Assessment of the Role of Serum 25-Hydroxy Vitamin D Level on Coronary Heart Disease Risk With Stratification Among Patients With Type 2 Diabetes Mellitus
Bener, A., Al-Hamaq, A. O. A. A., Zughaier, S. M., et al. (2020) · Angiology · doi:10.1177/0003319720951411 · Cited by 12
“The Diabetes Control and Complication Trial determined that hyperglycemia increases the development of diabetic macrovascular complications in patients with type 1 diabetes.(26) Glycemic control plays an key role to decrease the risk of all diabetes complications and mortality and morbidity because of CVD in patients…”
Background
The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
Benjamin, B. K., Qiu, C., Han, Z., Lu, W., Sun, G., Qin, X., Wang, X., Wang, X., Li, R., & Pan, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7580486 · Cited by 12
The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
Kountz, D. S. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0071-y · Cited by 12
A Comparison of Select Cardiovascular Outcomes by Antidiabetic Prescription Drug Classes Used to Treat Type 2 Diabetes Among Military Health System Beneficiaries, Fiscal Year 2003-2006
Casscells, S. W., Granger, E., Swedorske, J., Goldhammer, R., Shaheen, M., Dorris, J., Hong, A., & Wiktor, M. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817534d5 · Cited by 12
“The risk of death among individuals with diabetes is approximately 2 times that of similar aged individuals without diabetes.(13) Numerous studies have found that improv-”
Background
Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: A French adaptation of CARDS
Lafuma, A. J., Colin, X., & Solesse, A. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.05.003 · Cited by 12
Diabetes, aging and physical activity
Frier, B. C., Yang, P., & Taylor, A. W. (2006) · European Review of Aging and Physical Activity · doi:10.1007/s11556-006-0010-x · Cited by 13
“Not surprisingly, decreased life expectancy of ∼4 years among individuals diagnosed with DM aged 65–74 was reported [40].”
Background
The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
McDonald, C. G., Majumdar, S. R., Mahon, J. L., & Johnson, J. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2113 · Cited by 11
The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk
Yee, M., Pavitt, D. V., Dhanjil, S. K., Godsland, I. F., Richmond, W., & Johnston, D. G. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03089.x · Cited by 11
Two‐hour post‐load plasma glucose levels are associated with carotid intima‐media thickness in subjects with normal glucose tolerance
Kato, K., Otsuka, T., Kobayashi, N., Kon, Y., & Kawada, T. (2013) · Diabetic Medicine · doi:10.1111/dme.12288 · Cited by 11
Assessment of diabetes biomarker monitoring via novel biosensor activity
Kaur, H., Raveendran, A. V., Athwal, S., Verma, M., Mutreja, V., Ukhurebor, K. E., & Kusuma, H. S. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.100777 · Cited by 11
All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes
de Abreu, L. L. F., Holloway‐Kew, K. L., Mohebbi, M., Sajjad, M. A., Kotowicz, M. A., & Pasco, J. A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2042980 · Cited by 11
“Diabetes mellitus is a complex disease that is also increasing in prevalence and can lead to serious health complications, such as nephropathy [11], retinopathy [12], neuropathy [13], stroke [11], coronary artery disease [2], lower limb amputation [14], and early mortality [15, 16].”
Background
Prediction and early detection of cardiovascular disease in South Asians with diabetes mellitus
Wander, G. S., Bansal, M., & Kasliwal, R. R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.017 · Cited by 12
Diabetes Prevention and the Role of Risk Factor Reduction in the Medicare Population
Koller, E. A., Chin, J. S., & Conway, P. H. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.019 · Cited by 11
Cardiovascular Risk Attributable to Diabetes in Southern Brazil
Moreira, L. B., Fuchs, S. C. P. C., Wiehe, M., Neyeloff, J. L., Picon, R. V., Moreira, M. B., Gus, M., & Fuchs, F. D. (2009) · Diabetes Care · doi:10.2337/dc08-1948 · Cited by 11
Cardiovascular risk assessment and screening in diabetes
Zhao, Y. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000115 · Cited by 11
Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention
McNamara, D. B., Murthy, S. N., Fonseca, A. N., Desouza, C. V., Kadowitz, P. J., & Fonseca, V. A. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-098 · Cited by 11
“Diabetic patients have higher mortality rates due to cardiovascular disease and have not benefited from recent advances in interventional cardiology compared to patients without the disease (Gu et al. 1998; Przewłocki et al. 2000).”
Background
Branched-chain amino acids deficiency promotes diabetic cardiomyopathy by activating autophagy of cardiac fibroblasts
Zhou, Z., Song, K., Liu, Z., Ke, Y.-F., Shi, Y., Cai, K., Zhao, R., Sun, X., Tao, H., & Zhao, J.-Y. (2024) · Theranostics · doi:10.7150/thno.102708 · Cited by 13
Health risks associated with infertility and non-obstructive azoospermia
Huyghe, É., & Chiu, P. K. (2025) · Asian Journal of Andrology · doi:10.4103/aja20256 · Cited by 15
La carga de la diabetes en Cuba, período 1990-2005.
Alonso, E. D., Jo, A. H. S., Díaz, Ó. D., et al. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 10
Metabolic Profiling in Personalized Medicine: Bridging the Gap Between Knowledge and Clinical Practice in Type 2 Diabetes
Zolotov, S., Yosef, D. B., Rishe, N. D., Yesha, Y., & Karnieli, E. (2011) · Personalized Medicine · doi:10.2217/pme.11.36 · Cited by 10
The All-Cause Mortality and a Screening Tool to Determine High-Risk Patients among Prevalent Type 2 Diabetes Mellitus Patients
Bujang, M. A., Kuan, P. X., Tiong, X. T., Sapri, F. E., Ismail, M., Mustafa, F. I., & Hamid, A. M. A. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4638327 · Cited by 10
Mortality attributable to type 2 diabetes mellitus in Latin America and the Caribbean: a comparative risk assessment analysis
Guzman‐Vilca, W. C., & Carrillo-Larco, R. M. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002673 · Cited by 9
Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis
Etchegaray‐Morales, I., Pinto, C. M., Munguía‐Realpozo, P., Solís-Poblano, J. C., Méndez‐Martínez, S., Ayón-Aguilar, J., Abud‐Mendoza, C., García‐Carrasco, M., & Cervera, R. (2024) · Rheumatology · doi:10.1093/rheumatology/keae204 · Cited by 12
“DM increases the risk of cardiovascular morbidity and mortality [50].”
Background
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia
Sohn, K., Wende, A. R., Abel, E. D., Moreno, A. P., Sachse, F. B., & Punske, B. B. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.070235 · Cited by 10
“Heart disease is the major cause of diabetes-related morbidity and mortality, accounting for more than 70% of deaths in patients with diabetes (Gu et al. 1998; Grundy et al. 1999).”
The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
Saravia, M., Zeman, L., Ingolotti, M., et al. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.10.001 · Cited by 10
Coronary Atherosclerosis Assessment by Coronary CT Angiography in Asymptomatic Diabetic Population: A Critical Systematic Review of the Literature and Future Perspectives
Guaricci, A. I., Santis, D. D., Carbone, M., Muscogiuri, G., Guglielmo, M., Baggiano, A., Serviddio, G., & Pontone, G. (2018) · BioMed Research International · doi:10.1155/2018/8927281 · Cited by 10
Serum Adenosine Deaminase as a Useful Marker to Estimate Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients
Yu, M., Zhou, H., Li, Q., Ding, J., Shuai, H., & Zhang, J. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029621999722 · Cited by 10
“Cardiovascular disease is a major complication in patients with type 2 diabetes mellitus (T2DM), and T2DM patients increase the 2-3 folds risk of cardiovascular disease.(1) Contemporary data have showed that diabetes mellitus is close related with the risk of cardiovascular mortality.”
Background
Multiple metabolic risk factors and total and cardiovascular mortality in men with low prevalence of obesity
Park, H. S., Cho, S., Song, Y., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.08.027 · Cited by 10
The Need for Quality Management in Primary Health Care in Cyprus
Zachariadou, T., Makri, L., Stoffers, J., et al. (2006) · Quality Management in Health Care · doi:10.1097/00019514-200601000-00008 · Cited by 10
Diabetic Complications: Influence of Age, Sex, Family History, Duration, Glycemic Control and Obesity
Hameed, A., Malik, S., ., F.-R., et al. (2002) · Journal of Biological Sciences · doi:10.3923/jbs.2002.710.714 · Cited by 10
Coronary Risk Assessment in Subjects With Type 2 Diabetes Mellitus. General Population-Based Scores or Specific Scores?
Hernáez, R., Choque, L., Giménez, M., Costa, Á., Márquez, J. I., & Conget, I. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60633-6 · Cited by 10
“Regardless of any specific risk, the fact is that patients with DM2 present high morbidity and mortality due to cardiovascular events, and in recent years the reduction in mortality that has been observed in the general population has not been seen in this group.(17) These facts should motivate us to specify more prec…”
Background
Impact of Increasing Diabetes on Coronary Artery Disease in the Past Decade
Takaishi, H., Taniguchi, T., Fujioka, Y., et al. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.271 · Cited by 10
Diabetic Retinopathy in African Americans: Vision Impairment, Prevalence, Incidence, and Risk Factors
Baker, R. S. (2003) · International Ophthalmology Clinics · doi:10.1097/00004397-200343040-00011 · Cited by 12
“The significantly increased mortality suffered by blacks with diabetes compared to non-Hispanic whites with diabetes is an important consideration in comparing prevalence estimates.(20,33,34) This hypothesis is supported by the relatively low rate of severe retinopathy observed in the BES (0.”
Result
Estimación del riesgo coronario en pacientes con diabetes mellitus tipo 2. ¿Escalas de población general o escalas específicas?
Hernáez, R., Choque, L., Giménez, M., Costa, Á., Márquez, J. I., & Conget, I. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77149-3 · Cited by 12
Impact of Medication Therapy Management on Underserved, Primarily Hispanic Patients with Diabetes
Congdon, H. B., Dowling, T. C., Cheng, I., & Truong, H.-A. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r648 · Cited by 10
A Missing Data Estimation Analysis in Type II Diabetes Databases
Giardina, M., Huo, Y., Azuaje, F. J., et al. (2005) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2005.13 · Cited by 10
“The risk of coronary heart disease is two to four times greater in individuals with diabetes than those without diabetes [ 2 , 3].”
Background
Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus
Hovens, M. M. C., Tamsma, J. T., Beishuizen, E. D., & Huisman, M. V. (2005) · Drugs · doi:10.2165/00003495-200565040-00001 · Cited by 10
Age-related differences in preventive care among adults with diabetes
Persell, S. D., Zaslavsky, A. M., Weissman, J. S., & Ayanian, J. Z. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.038 · Cited by 10
Lifestyle Medicine Strategies for Risk Factor Reduction, Prevention, and Treatment of Coronary Heart Disease: Part II
Rippe, J. M., Angelopoulos, T. J., & Zukley, L. M. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827606297759 · Cited by 10
“Diabetes is a signifi cant risk factor for CHD, which represents the leading cause of death for both diabetic men and women.(81) A variety of lifestyle measures such as weight loss in overweight or obese individuals and regular physical activity play important roles in the management of diabetes.”
Background
Insulin resistance and atherosclerosis in diabetes mellitus
Wollesen, F., Berglund, L., & Berne, C. (2002) · Metabolism · doi:10.1053/meta.2002.32721 · Cited by 10
Epidemiology of Type 2 Diabetes
Ronald, C. W., & Tong, P. C. Y. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch5 · Cited by 10
Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
Hommels, T. M., Hermanides, R. S., Fabris, E., & Kedhi, E. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01844-1 · Cited by 10
Fruit and Vegetable Consumption and Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Systematic Review and Dose–Response Meta-analysis of Prospective Cohort Studies
Geravand, F., Montazer, M., Mousavi, S. M., & Azadbakht, L. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf013 · Cited by 9
Estimation of Expected Life-Years Saved From Successful Prevention of End-Stage Renal Disease in Elderly Patients With Diabetes
Yang, D., Lee, L. J., Hsu, C.-C., Chang, Y., Wang, M.-C., Lin, W., Chang, C., & Wang, J. (2012) · Diabetes Care · doi:10.2337/dc12-0545 · Cited by 9
“Moreover, such a control program would generally produce spillover effects on reducing cardio- and cerebrovascular morbidities and mortalities, especially among the elderly (37,38).”
Background
Improvement of cardiovascular risk assessment in Type 2 diabetes by the addition of carotid artery intima–media thickness to Framingham risk score: A retrospective cohort study
Ataoğlu, H. E., Saler, T., Uzunhasan, I., et al. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00032.x · Cited by 9
Lifestyle characteristics and 3-year total mortality of Japanese with self-reported diabetes
Yokokawa, H., Goto, A., Abe, Y., Suzuki, S., & Yasumura, S. (2008) · Health & Social Care in the Community · doi:10.1111/j.1365-2524.2008.00787.x · Cited by 9
How Important Is Diabetes as a Risk Factor for Cardiovascular and Other Diseases in Older Adults?
Kengne, A. P., & Patel, A. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030424 · Cited by 9
Ethnic differences in cause specific mortality among hospitalised patients with diabetes: a linkage study in New Zealand
Jeffreys, M., Wright, C., Mannetje, A. ’., Huang, K., & Pearce, N. E. (2005) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2005.037515 · Cited by 9
Association between serum haptoglobin and carotid arterial functions: usefulness of a targeted metabolomics approach
Wang, S., Wang, J., Zhang, R., Zhao, A., Zheng, X., Yan, D., Jiang, F., Jia, W. P., Hu, C., & Jia, W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0808-2 · Cited by 10
“Background Type 2 diabetes mellitus (T2DM) represents a heterogeneous group of chronic metabolic disorders, and its increasing prevalence has led to an explosion of the global disease burden with increased mortality and morbidity [1, 2].”
Background
Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus
Taylor, A. M., McNamara, C. A., Hedelt, A., et al. (2005) · Therapy · doi:10.2217/14750708.2.4.587 · Cited by 9
“Analysis of the National Health And Nutrition Examination Survey (NHANES) data follow up suggests that men with DM do not benefit from the societal reduction in coronary heart disease morbidity and mortality of the general population; moreover, women with diabetes are reported to have an increasing mortality related t…”
Background
The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease
Rippe, J., Angelopoulos, T., & Zukley, L. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827606292859 · Cited by 11
“More than 75% of all mortality in diabetic patients is the result of CHD.(71) Approximately 8% of the US population has diabetes (18.”
Background
The use of computers in population-based diabetes management
Grant, R. W. (2014) · Cited by 9
Diabetic Retinopathy in African Americans: Vision Impairment, Prevalence, Incidence, and Risk Factors
Baker, R. S. (2003) · International Ophthalmology Clinics · doi:10.1097/00004397-200304340-00011 · Cited by 9
Epidemiology of Peripheral Vascular Disease
Wheeler, S., Smith, N., & Boyko, E. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:419 · Cited by 6
Protocol for partnering with peers intervention to improve medication adherence among African Americans with Type 2 DiabetesPreprint
Shiyanbola, O. O., Maurer, M. A., Ward, E. C., Sharp, L. K., Lee, J., & Tarfa, A. (2020) · medRxiv · doi:10.1101/2020.06.04.20122895 · Cited by 7
Qualidade da informação sobre mortalidade numa coorte de diabéticos - Estado do Rio de Janeiro, 2000 a 2003
Cascão, Â. M., Costa, A. J. L., & Kale, P. L. (2012) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2012000100012 · Cited by 8
The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population
Jung, C. H., Seo, G. H., Suh, S., Bae, J. C., Kim, M. K., Hwang, Y., Kim, J. H., & Lee, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128627 · Cited by 8
Autoimmune diabetes in adults and risk of myocardial infarction: the HUNT study in Norway
Laugsand, L. E., Janszky, I., VATTEN, L. J., Dalen, H., Midthjell, K., Grill, V., & Carlsson, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12530 · Cited by 8
Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study
McGrath, B., Norris, C., Hardwicke-Brown, E., Welsh, R., & Bainey, K. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw055 · Cited by 9
Prevalence and Factors Associated with Microalbuminuria among Type 2 Diabetic Patients : A Hospital Based Study
Khadka, B., Tiwari, M. L., Timalsina, B., et al. (2018) · Journal of Nepal Medical Association · doi:10.31729/jnma.3469 · Cited by 8
Fracture Risk in Women with Dysglycaemia: Assessing Effects of Baseline and Time-Varying Risk Factors
de Abreu, L. L. F., Holloway‐Kew, K. L., Mohebbi, M., Sajjad, M. A., Kotowicz, M. A., & Pasco, J. A. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0498-x · Cited by 8
Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., Ijsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., Luca, G. D., & Kedhi, E. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0827-z · Cited by 8
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Caterina, R. D., Patti, G., Westerbergh, J., Horowitz, J. D., Ezekowitz, J. A., Lewis, B. S., Lópes, R. D., McMurray, J. J. V., Atar, D., Bahit, M. C., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa140 · Cited by 8
“19–22 Our findings may be specific to patients with AF treated with anticoagulation.”
“I Kept Coming for the Love”
Raffel, K. E., Goddu, A. P., & Peek, M. E. (2014) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721714522861 · Cited by 10
“57 Single 47 (17) 33 (5) Married/living as married 17 (6) 27 (4) Separated/divorced/widowed 36 (13) 40 (6) Education 1.”
Grape Seed Procyanidins Improve Diabetic Symptoms in Mice with Streptozotocin-Induced Diabetes
Hsi, S., Kao, Y.-P., Wang, P.-Y., et al. (2009) · The Open Physiology Journal · doi:10.2174/1874360900902010006 · Cited by 8
“The economic costs, prevalence, morbidity, and mortality associated with prediabetic conditions and diabetes are high [2-9].”
Background
Diabetes and number of years of life lost with and without cardiovascular disease: a multi-state homogeneous semi-Markov model
Ramezankhani, A., Azizi, F., Hadaegh, F., & Momenan, A. A. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1083-x · Cited by 8
Diagnosis of Diabetes Mellitus in Older Adults
Reddy, S. S. K. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.011 · Cited by 7
Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: A critical review
Yerramasu, A. K., Venuraju, S. M., Lahiri, A., & Anand, D. V. (2008) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.11.001 · Cited by 8
“Coronary artery disease (CAD) accounts for 70% of the deaths among diabetic patients.(1) Patients with diabetes have a 2-to-4-fold higher risk of cardiac events than their nondiabetic counterparts.”
Background
Cardiovascular fitness and type 2 diabetes
Mullooly, C. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0109-z · Cited by 8
“When looking at causes of death listed on death certificates in the United States, only 36% of men and 47.2% of women with diabetes had it listed on the death certificate [ 12 ].”
BackgroundInfluential
A nutrition and diabetes education program improves A1c knowledge and A1c blood levels
Burnett, S. (2003) · Cited by 8
A Mortalidade por Diabetes em Portugal
Boavida, J. M., Pereira, M., & Ayala, M. (2013) · Acta Médica Portuguesa · doi:10.20344/amp.4800 · Cited by 7
Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging
Noale, M., Maggi, S., Zanoni, S., Limongi, F., Zambon, S., & Crepaldi, G. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.06.004 · Cited by 7
Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Kim, J.-Y., Yang, S., Lee, J. I., & Chang, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153502 · Cited by 7
“To assess the cardiovascular (CV) risk associated with the use of incretin-based therapy in adult patients with type 2 diabetes mellitus (T2DM) primary prevention group with low CV risks.”
BackgroundInfluential
Predictors of Mortality in Takotsubo Cardiomyopathy
El‐Battrawy, I., Borggrefe, M., & Akın, İ. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.684 · Cited by 7
The association of glycated hemoglobin A1c with coronary artery disease, myocardial infarction, and severity of coronary lesions
Wei, Y., Li, W., Luan, H., Tuerhongjiang, G., Yuan, Z., & Wu, Y. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221140593 · Cited by 8
Alterations of the Ca2+ clearing mechanisms by type 2 diabetes in aortic smooth muscle cells of Zucker diabetic fatty rat
Moreno, A., Coyotl-Santiago, N., Moreno-Vazquez, R., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1200115 · Cited by 7
“The most common cause of death among diabetic patients is represented by cardiovascular disorders with heart disease causing approximately 70% of patients’ deaths (Gu et al., 1998; Einarson et al., 2018).”
Background
Type 2 Diabetes, Immunity and Cardiovascular Risk: A Complex Relationship
Pedicino, D., Francesca, A., Alessandro, V., Trotta, F., & Liuzzo, G. (2012) · InTech eBooks · doi:10.5772/50611 · Cited by 7
Palliative and end of life care for people with diabetes: a topical issue
Dunning, T. L., Savage, S., Duggan, N., & Martin, P. (2014) · Diabetes Management · doi:10.2217/dmt.14.33 · Cited by 7
Linagliptin for the treatment of type 2 diabetes
Prato, S. D. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.613825 · Cited by 7
“Approximately 50 -- 80% of patients with T2D die of cardiovascular causes [2,3], and the prevalence of obesity, hypertension and renal disease in this patient population is well known.”
Background
Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project
Ohmura, H., Mita, T., Matsuoka, J., Nojiri, S., Nishizaki, Y., Watada, H., Daida, H., & SPIRITS-J Study Investigators (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0626-2 · Cited by 7
The 1‑year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study
Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., Ijsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., Luca, G. D., & Kedhi, E. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-1293-7 · Cited by 7
Diabetes Mellitus and Heart Disease
Johnstonemd, M. T., & Kinzfogl, G. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:579 · Cited by 7
Refined method for estimating medical expenditures for liver disease using the patient survey and claim data in Japan.
Toyokawai, S., Kobayashi, Y., & Ohmori, M. (2005) · PubMed · Cited by 7
Management of dyslipidemia in elderly diabetic patients
Verny, C. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)73655-7 · Cited by 6
“Vascular complications are the main causes of morbidity and mortality in patients with type 2 diabetes [2], known to be a source of overmortality, even in the elderly population [3], and higher cardiovascular morbidity and mortality [4-6].”
Background
A nurse-managed diabetes care programme
Pishdad, G. R., Pishdad, R., & Pishdad, P. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01406.x · Cited by 7
Dyslipidemia in Diabetes
Subramanian, S., & Chait, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65798-7 · Cited by 9
Acetylsalicylic acid (Aspirin) for primary prevention of cardiovascular disease in type 2 diabetes mellitus
Hovens, M. M. C., de Laar, F. A. V., Cannegieter, S. C., et al. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005446 · Cited by 7

Authors: Gu, K., Cowie, C. C., & Harris, M. I.
Affiliations: National Institutes of Health (US)
ORCID: Gu, Ken
Cowie, Catherine C
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 1998-07-01
Volume: 21
Issue: 7
Pages: 1138-1145
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.21.7.1138
OpenAlex: W2050695519
Cited by: 881
References: 0
Citations by year: 2026: 1 · 2025: 12 · 2024: 15 · 2023: 11 · 2022: 21 · 2021: 25 · 2020: 25 · 2019: 27 · 2018: 33 · 2017: 39 · 2016: 36 · 2015: 26 · 2014: 32 · 2013: 44 · 2012: 48
FWCI: 10.98
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: diabetes mortality, causes of death, life expectancy, survival, sex differences, racial differences, non-Hispanic blacks, insulin-treated diabetes, diabetes duration, heart disease, death certificates, adults with diabetes, age differences in mortality risk, cancer
MeSH terms: Adult, Aged, Cause of Death, Diabetes Mellitus, Female, Humans, Life Expectancy, Male, Middle Aged, Mortality, Population, United States, Cohort Studies, Survival Rate, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks